Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics

These two could become direct competitors relatively soon. Wave Life Sciences (WVE 6.39%) and Sarepta Therapeutics (SRPT 0.15%) are both riskier than the typical biotech, even when considering their stage of maturity. But with more uncertainty often comes more upside for risk-tolerant investors, and both companies are without a doubt on the very forefront of medicine, pushing the envelope beyond what was previously possible. Still, there's a clear winner here from an investment perspective, so let's analyze ...